Exogenous HRG and MMP proteolytic enzymes (MMP2, MMP9) were shown to enhance the adhesion and TEM across BE in HER2/3-expressing luminal breast cancer cell lines (MDA-MB-361, MCF-7, SKBr3). This evidence concerns the gene ERBB2 and breast carcinoma.